In the last year, some drugmakers have pulled back from the sector, including Pfizer, which recently stopped selling its gene ...

Customers who struggle to afford the $1,000-plus list price for weight-loss drugs Zepbound and Wegovy can buy now and pay ...

Drugmakers are urging the Trump administration and European Union officials to exclude medical goods from expanding tariff ...

The new generation of weight-loss drugs are a boon for the overweight, but they also promise to change our relationship with ...

The trial results are critical, as it brings Eli Lilly’s pill one step closer to becoming a new, needle-free alternative for ...

It was only a matter of time until the GLP-1 receptor agonist drugs like Ozempic and Wegovy were superseded, and now it looks ...

The federal government allows compounding pharmacies to sell copies of drugs when the medications are in short supply. Yet federal regulators recently declared the blockbuster weight-loss drugs ...

Hims & Hers (HIMS), the millennial-skewed telehealth company, saw its stock tumble nearly 9% on Tuesday, as the company ...

Companies that sell compounded weight loss drugs vowed to continue to help their customers. “We will continue to work to ensure that our patients can access the best treatments for their ...

How weight loss drugs actually work, and how big-name prescriptions differ from each other. What investors need to know about Ozempic's and Mounjarno's patent cliffs. The scenarios in which Novo ...

Hims and Hers' stock fell over 19% in after-hours trading on Monday after its CEO said the company would no longer sell compounded versions of mega-hit weight loss drugs. "We will have to start ...

Hims & Hers (HIMS) made a killing last year selling an off-brand version of ... subscription for popular GLP-1 diabetes and weight-loss drugs Ozempic and Wegovy. These drugs work by mimicking ...